Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study
Journal of Ocular Pharmacology and Therapeutics · 2025
DOI: 10.1089/jop.2024.0165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Maxime Quirke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, CHU Charles Nicolle, Rouen, France. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Cornea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, CHU Charles Nicolle, Rouen, France.
- Department of Pharmacology, CHU Charles Nicolle, Rouen, France.
- Rouen Medical Training Center, CHU Charles Nicolle, Rouen, France.
- EA 7510 Epidemio-surveillance and circulation of parasites in the environment, Faculty of Medicine and Pharmacy, Rouen University, Rouen, France.
ORCID-Profile: Maxime Quirke, Julie Gueudry
Zitieren
APA
Quirke, M., Lamoureux, F., Arnoult, C., Gress, G., Ganem, A., Charpentier, T., Muraine, M., & Gueudry, J. (2025). Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0165
Vancouver
Quirke M, Lamoureux F, Arnoult C, Gress G, Ganem A, Charpentier T, et al. Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2024.0165
BibTeX
@article{Quirke2025,
author = {Quirke, Maxime and Lamoureux, Fabien and Arnoult, Christophe and Gress, Gladys and Ganem, Ariella and Charpentier, Théophile and Muraine, Marc and Gueudry, Julie},
title = {Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2025},
doi = {10.1089/jop.2024.0165}
}
EUVIMED